WeedMD launches product collaboration with CannTx Life Sciences

WeedMD Inc (CVE:WMD) (OTCQX:WDDMF) (FRA:4WE) said it has entered into an exclusive licensing and supply agreement with craft cannabis producer CannTx Life Sciences Inc to release what it says are “celebrated” cultivars ‘Rockstar Tuna’ and ‘Royal Goddess’, re-labeled as ‘Crown’, for its Starseed Medicinal patients. 

The medical-grade cannabis producer said the limited edition release of the high-THC whole flower products will be available from late May. 

READ: WeedMD appoints former Tilray Canada executive Beth Carreon as CFO

“We pride ourselves on hand-crafting artisanal, small-batch products that are appreciated by discerning patients, and we’re thrilled to be collaborating with a producer that shares our brand ethos. WeedMD is a long-time, highly valued partner that has built a strong distribution network and reputation for excellence and we’re looking forward to continuing to bring more innovative products to market together,” CannTx director and co-founder Buck Young said in a statement.

“This unique partnership is a natural fit for both WeedMD and CannTx, bringing together complementary renowned cultivars, with distinctive terpene profiles, that are hand-crafted for our medical patients by this University of Guelph-affiliated micro-propagator. We continue to advance our drive for excellence by selecting exclusive licensing partnerships with teams that are passionate about quality cannabis. Together, we’re proud to be leading the wave of change that is bringing greater choice, quality, and value in cannabis products for Canadians,” added Joseph Mele, senior vice president of commercial sales and marketing at WeedMD.

Contact the author at [email protected]

Follow him on Twitter @Cal_Proac

Story by ProactiveInvestors